Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichi Oikawa

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Diabetology International|October 22, 2020
Possible involvement of autoimmunity in fulminant type 1 diabetesYoichi Oikawa, Akira Shimada
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 16, 2015
[Type 1 diabetes]Yoichi Oikawa, Akira Shimada
The Review of Diabetic Studies : RDS|June 15, 2007
Improved Monitoring of the Hyperglycemic State in Type 1 Diabetes Patients by Use of the Glycoalbumin/HbA1c RatioTakatoshi Imai, Yoichi Oikawa, Akira Shimada
Journal of Diabetes Investigation|July 30, 2023
Real-world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium-glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score-matched model analysis in JapanTakeshi Horii, Yoichi Oikawa, Akira Shimada, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 15, 2007
[Chronic kidney diseases and other diseases: 6. Obesity]Toshihide Kawai, Akira Shimada, Yoichi Oikawa, et al.
Journal of Diabetes Investigation|January 15, 2021
On-label use of sodium-glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetesTakeshi Horii, Yoichi Oikawa, Koichiro Atsuda, et al.
Journal of Diabetes Investigation|April 9, 2025
Update on slowly progressive type 1 diabetesYoichi Oikawa, Akifumi Haisa, Atsushi Satomura, et al.
Diabetology International|January 21, 2022
Dupilumab-related type 1 diabetes in a patient with atopic dermatitis: a case reportYasuharu Kurokawa, Yoichi Oikawa, Akira Shimada, et al.
Annals of the New York Academy of Sciences|November 30, 2006
T cell immunity to glutamic acid decarboxylase in fulminant type 1 diabetes without significant elevation of serum amylaseKanemi Aoki, Matsuo Taniyama, Chieko Nagayama, et al.
Diabetes Care|July 30, 2002
A case of fulminant type 1 diabetes with strong evidence of autoimmunityAkira Shimada, Yoichi Oikawa, Toshikatsu Shigihara, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Diabetology International|October 22, 2020
Possible involvement of autoimmunity in fulminant type 1 diabetesYoichi Oikawa, Akira Shimada
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 16, 2015
[Type 1 diabetes]Yoichi Oikawa, Akira Shimada
The Review of Diabetic Studies : RDS|June 15, 2007
Improved Monitoring of the Hyperglycemic State in Type 1 Diabetes Patients by Use of the Glycoalbumin/HbA1c RatioTakatoshi Imai, Yoichi Oikawa, Akira Shimada
Journal of Diabetes Investigation|July 30, 2023
Real-world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium-glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score-matched model analysis in JapanTakeshi Horii, Yoichi Oikawa, Akira Shimada, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 15, 2007
[Chronic kidney diseases and other diseases: 6. Obesity]Toshihide Kawai, Akira Shimada, Yoichi Oikawa, et al.
Journal of Diabetes Investigation|January 15, 2021
On-label use of sodium-glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetesTakeshi Horii, Yoichi Oikawa, Koichiro Atsuda, et al.
Journal of Diabetes Investigation|April 9, 2025
Update on slowly progressive type 1 diabetesYoichi Oikawa, Akifumi Haisa, Atsushi Satomura, et al.
Diabetology International|January 21, 2022
Dupilumab-related type 1 diabetes in a patient with atopic dermatitis: a case reportYasuharu Kurokawa, Yoichi Oikawa, Akira Shimada, et al.
Annals of the New York Academy of Sciences|November 30, 2006
T cell immunity to glutamic acid decarboxylase in fulminant type 1 diabetes without significant elevation of serum amylaseKanemi Aoki, Matsuo Taniyama, Chieko Nagayama, et al.
Diabetes Care|July 30, 2002
A case of fulminant type 1 diabetes with strong evidence of autoimmunityAkira Shimada, Yoichi Oikawa, Toshikatsu Shigihara, et al.
Pageof 11